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ABSTRACT
Background    Autism spectrum disorders (ASD) with 
intellectual disabilities may be associated with many 
factors. This study focused on patients with ASD with 
intellectual disabilities, defined by a threshold intelli-
gence quotient (IQ) or development quotient (DQ) of 70. 
We also discuss comorbidities and other factors related 
to ASD.
Method    We extracted case records of patients born be-
tween April 1995 and March 2001 who lived in Yonago 
City, as of January 2011, and had visited the two special-
ist institutions for consultation regarding developmental 
issues. The list was further narrowed down to patients 
identified, as having ASD by pediatric neurologists 
based on Diagnostic and Statistical Manual of Mental 
Disorders (Fifth Edition) (DSM-5). We selected patients 
with < IQ/DQ 70 using the most recent intelligence/
development test to determine comorbidities and other 
factors related to ASD.
Results    The data of 81 patients (59 males and 22 
females) were extracted, corresponding to an incidence 
of 76.2 patients out of every 10,000 births. The male-to-
female ratio was 2.7:1. Comorbidities and related factors 
of ASD were observed in 25 cases (30.9%). Eleven cases 
had perinatal abnormalities. Other abnormalities were 
observed in 17 cases, including epilepsies in 7, chromo-
somal abnormalities in 4, familial mental retardation in 1, 
and acquired brain injury in 1.
Conclusion    It is important to treat and support indi-
viduals with ASD and intellectual disabilities taking 
into account the characteristics and prognosis of the 
comorbidities and related factors.
Key words    autism spectrum disorder; intellectual 
disabilities; incidence; related factors
Since the report by Lotter1, several studies have reported 
on the increasing prevalence of autism spectrum disor-
ders (ASD) (Table 1). However, some researchers believe 
that this rise is only superficial and that it is attributable 
to the differences in research methods, regions, and 
diagnostic criteria.2, 3 Diagnostic criteria refers to ex-
pansion of the definition of ASD, changes in diagnostic 
standards, improvements in diagnostic technology, age 
at diagnosis, and the ability to distinguish between mild 
and severe symptoms.1, 4, 5
 In Japan, many studies utilize the infant health 
checkup system. However, the findings of past reports 
were affected by subjects’ low age and frequent relo-
cation, given that many study populations resided in 
metropolitan areas. Individuals living in Yonago City, 
in the Tottori Prefecture, have lower rates of relocation, 
compared to people residing in metropolitan areas. 
Yonago City has several medical facilities and features 
close coordination among medical, educational, and so-
cial welfare institutions. Thus, children with intellectual 
disabilities receive good support from an early stage in 
Yonago city.
 Children with ASD without intellectual disabilities 
exhibit symptoms caused by functional abnormalities 
in the brain before birth and, in recent years, several 
reports have identified specific genes that are responsible 
for this condition.6 On the other hand, symptom of ASD 
with intellectual disorders is believed to be associated 
with genetic factors, perinatal brain injuries, and 
postnatal brain injuries. In this study, we investigated 
ASD with intellectual disabilities with a focus on its 
incidence, comorbidities, and related factors.
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SUBJECTS AND METHODS
Tested area
The population of Yonago City, Tottori Prefecture 
was 148,090 people in December 2010. The total area 
is 132.2 km2, with limited migration to and from the 
city, unlike metropolitan areas. Individuals suspected 
of exhibiting language or developmental problems are 
typically referred to the Division of Child Neurology 
at Tottori University Hospital or Tottori Prefecture 
Rehabilitation Center for Children with Disabilities.
Screening system in Yonago City
In Yonago city, there are 5 timepoints at which a child’s 
developmental status is checked; 6-month checkup; 
18-month- checkup; 3-year- checkup: developmental 
consultation at 5-years-old; and when meeting with the 
School Guidance Committee.
 At the 6-month-, 18-month-, and 3-year- health 
checkups, public health nurses check each child’s 
sociability and cognitive development. Cases with sus-
pected language or developmental problems are referred 
to Tottori University Hospital or Tottori Prefecture 
Rehabilitation Center for Children with Disabilities for 
diagnosis. Thereafter, parents of children with develop-
mental disorders often seek support from child-care fa-
cilities in the city or seek occupational therapy, physical 
therapy, or social skill training.
 The 5-year developmental consultation can be 
conducted at the parent’s request. Information about 
group and interpersonal behaviors is provided by mul-
tiple sources, from nursery schools to doctors. Children 
suspected of exhibiting intellectual disabilities or devel-
opmental disorders are referred to the above-mentioned 
medical facilities.
 The School Guidance Committee consists of child 
psychologists, child neurologists, clinical psychologists, 
and school teachers. Children facing challenges or with 
behavioral issues may be referred to these specialized 
institutions, with input from the School Guidance 
Committee to assist parents with determining the most 
suitable school for their children. Teachers who spe-
cialize in developmental disorders perform rounds at 
elementary and junior high schools to advise the schools 
on issues related to children with suspected intellectual 
disabilities or developmental disorders, and coordinate 
hospital visits. In Yonago City, this process is used to 
identify children with developmental disorders and intel-
lectual disabilities at an early stage.
Subjects
Case records were extracted for patients who visited 
the Division of Child Neurology at Tottori University 
Hospital or the Tottori Prefecture Rehabilitation Center 
for Children with Disabilities for consultation on devel-
opmental issues. Patients born between April 1995 and 
March 2001 residing in Yonago City at the end January 
Table 1. Prevalence of autism spectrum disorders
Author Investigation area
Age of 
subjects
Prevalence (/10,000)
Criteria
Total
Intelligent level*
LFA HFA
Lotter V (1966)1 UK 8–10 4.5 3.8 0.6 Infantile autism (Kanner)
Wing & Gould (1979)7 UK 0–14 26.1 – – Traiad
Ishi & Takahashi (1983)8 Japan 6–12 16.0 13.4 2.6 DSM-Ⅲ
Sugiyama & Abe (1989)9 Japan 3 13.0 – – DSM-Ⅲ
Honda et al. (1996)10 Japan 5 21.1 10.6 10.6 DSM-Ⅲ
Chakrabarti&Fombonne (2001)11 UK 2.5–6.5 62.6 16.3 46.3 DSM-ⅢR,DSM-Ⅳ
Sumi et al. (2004)12 Japan 6-8 212.4 65.6 146.8 DSM-Ⅳ
Honda et al. (2005)13 Japan 5 27.2 22.6 7.6 ICD-10
Baird et al. (2006)14 UK 9–10 116.1 65.0 51.1 ICD-10, ADI-R, ADOS
Kawamura et al. (2008)15 Japan 1–7 181.1 59.6 117.6 DSM-Ⅳ
Baron-Cohen et al. (2009)16 UK 5–9 157.0 – – ICD-10, ADI-R, ADOS
Kim et al. (2011)17 Korea 7–12 264.0 – – ASSQ, ADI-R, ADOS
Imai & Ito (2014)18 Japan 5 374.4 118.4 232.4 DSM-5
*Intelligence level was classified as follows except for the study of Lotter V: high function autism (HFA) was ≥ IQ/DQ70 and low function 
autisms (LFA) was < IQ/DQ70. Lotter (1966) classified HFA if the IQ/DQ was ≥ 85 and LFA if the IQ was < IQ85.  
ADI-R, autism diagnostic interview-revised; ADOS, autism diagnostic observation schedule; ASSQ, autism spectrum screening ques-
tionnaire; DSM, diagnostic and statistical manual of mental disorders; DQ, developmental quotient; ICD, international classification of 
diseases; IQ, intelligent quotient.
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2011 were included. The study group was further limited 
to children diagnosed with autistic disorder or pervasive 
developmental disorder (PDD) by child neurologists, 
based on DSM-IV criteria. After the introduction of 
DSM-5 in 2014, PDD and autistic disorder were integrat-
ed to form ASD. Therefore, the term of “ASD” was used 
in this study.
 Of the patients identified by the above criteria, those 
with an IQ/DQ score of < 70 on the most recent intelli-
gence/development test were enrolled as study subjects. 
The present research was approved by the Institutional 
Review Board of Tottori University (No. 1215).
RESULTS
Incidence of ASD and male/female ratio
Eighty-one children (59 males, 22 females) were diag-
nosed ASD with intellectual disabilities and the mean 
annual incidence was 76.2 of 10,000 births. Table 2 
shows the annual incidence rates of ASD with intellectu-
al disabilities. Patients’ ages at the time of the evaluation 
ranged from 8 years 11 months to 14 years 10 months. 
The male: female ratio was 2.7:1.
Intellectual development
IQ or DQ were obtained for 73 cases. IQ and DQ were 
not obtained for eight cases because of severe mental 
retardation. Alternatively, these children were graded as 
demonstrating a severe disability (IQ/DQ ≤ 34). Other 
tests administered to the children included the Wechsler 
Intelligence Scale for Children III (WISC-III) (41.4%), 
Tanaka-Binet Intelligence ScaleⅤ (38.6%), Kyoto Scale 
of Psychological Development Test (11/4%), and the 
Enjoji Infantile Development Test (7.1%). Three boys 
had IQ/DQ scores, but the test name was not specified. 
There were 71 cases where the test date was stated in the 
patient record. The mean patient age at testing was 106 
months (8 years and 10 months) (SD = 38.3).
 All included cases were divided into three categories 
IQ/DQ scores of ≤ 34 (severe disability), 35–49 (moderate 
disability), and 50–69 (mild disability), accounting for 
32.1%, 18.5%, and 49.4% of all subjects, respectively 
(Table 3)
Type of school attended
Forty-three patients (30 males, 13 females) were attend-
ing a special support education school at the time of 
testing, and 38 were attending normal classes or special 
needs classes at local schools.
Information in perinatal period
Gestational ages of 47 patients were obtained from the 
medical records, and the average gestational age was 
38 weeks 5 days (SD = 19.7 days). Records related to 
body weight at time of birth were obtained from 53 
patients, and the average weight was 2995.4 g (SD = 
549.9). Records related to height at time of birth were 
Table 2. Annual incidence of ASD with intellectual disabilities and sex ratio
Birth year The number of patients with ASD Birth cohort Incidence/10,000 birth Sex ratio (Male : Female)
Male Female Total
1995 8 4 12 1,409 85.2 2 : 1
1996 7 3 10 1,446 69.2 2.3 : 1
1997 10 2 12 1,472 81.5 5 : 1
1998 9 3 12 1,624 73.9 3 : 1
1999 9 5 14 1,547 90.5 2 : 1
2000 7 2 9 1,581 56.9 3.5 : 1
2001 9 3 12 1,551 77.4 3 : 1
Total 59 22 81 10,630 76.2 2.7 : 1
ASD, autism spectrum disorders.
Table 3. Distribution of IQ/DQ in patients of Autism 
Spectrum Disorders with intellectual disabilities
IQ/DQ ≤ 34 35–49 50–69
IQ Male 6 8 27
Female 1 5 9
Total 7 13 36
DQ Male 8 0 1
Female 1 0 3
Total 9 0 4
Test name undescribed Male 1 2 0
Female 1 0 0
Total 2 2 0
Test not obtained Male 6 0 0
Female 2 0 0
Total 8 0 0
Total Male 21 10 28
Female 5 5 12
Total 26 15 40
32.1% 18.5% 49.4%
DQ, development quotient; IQ, intelligence quotient.
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obtained from 34 patients, and average height was 47.6 
cm (SD = 3.4). Records related to head circumference 
were obtained for 29 patients, and the average was 
32.4 cm (SD = 6.8). Father’s age was obtained for 49 
patients, and the average was 34.1 years (SD = 14.2). 
Regarding father’s age at time of birth, 5 (9.8%) were 
20–24-years old, 14 (28.6%) were 25–29-years old, 
18 (38.3%) were 30–34-years old, 11 (23.4%) were 
35–39-years old, 2 (3.8%) were 40–44-years old and 1 
(1.9%) was 45–50-years old. Mother’s age was obtained 
for 53 patients, and the average was 30.7 years (SD = 
9.9). Regarding mother’s age at time of birth, 6 (11.3%) 
were 20–24-years old, 18 (34.0%) were 25–29-years 
old, 26 (49.1%) were 30–34-years old, 2 (3.8%) were 
35–39-years old and 1 (1.9%) was 42-years old. Data on 
birth order was obtained for 50 patients. We found that 
29 children were firstborn, 20 were second born, and 1 
was fourth born. The average age of the mother at time 
of birth was 29.1 years (SD = 4.8) for the first-born child 
and 33.5 years for the second-born child (SD = 14.9).
Comorbidities
In 25 cases (30.9%), comorbidities, perinatal problems, 
and other factors related to ASD were identified. There 
were 53 cases where data were obtained for the perinatal 
period. Of these, 11 showed perinatal abnormalities 
(11/53 cases, 20.8%). There was one case of very low 
birth weight (< 1,000 g) at 686 g, 4 cases of low birth 
weight (2500 g or less), 3 cases of neonatal asphyxia, 
and 3 cases of meconium aspiration syndrome.
 For other comorbidities and related factors, there 
were 4 cases of chromosomal or congenital abnormal-
ities, 7 cases of epilepsy, 4 cases of congenital brain 
anomalies, 1 case of familial developmental disorder, 
and 1 case of acquired brain injury (Table 4).
DISCUSSION
The annual incidence of ASD plus intellectual disabil-
ities in children was 76.2 out of every 10,000 births. 
This is lower than the rate reported by Imai and Ito18 
but higher than that reported in other studies (Table 
1). Fombonne et al19 reported that 8–12 years is ideal 
for diagnosis of developmental disorders, since that is 
when concrete intellectual symptoms appear that can be 
recognized by other people and, in many children, ASD 
symptoms become apparent at that age. In some chil-
dren with ASD, intellectual disabilities that could not be 
discerned during childhood gradually emerge alongside 
intellectual development. The patients in the present 
study ranged in age from 8 years 11 months to 14 years 
10 months and all were suitable for formal evaluation of 
ASD symptoms. Generally, study populations for this 
condition include more males than females, with a male-
to-female ratio of 2.7:1 reported by Honda et al.,14 3.2:1 
by Kawamura et al.,16 and 2.7:1 in the present study.
 Many recent studies have reported other factors 
related to ASD occurring in the perinatal and neonatal 
periods. These factors included low birth weight,20–24 
meconium aspiration syndrome,20, 24 older father,22, 25 
older mother,26, 27 and both parents of advanced age.26, 27, 28 
In addition, reproductive medicine29 and umbilical cord 
coiling20 have appear to be related factors. However, 
these factors have mainly been studied in children with 
ASD without intellectual disabilities, and caution must 
be taken when applying these findings to children with 
ASD who demonstrate concomitant intellectual disabili-
ties.
 In this study, 5 patients had a low birth weight of 
≤ 2500 g. Although it has been reported that ASD is 
more frequent in children with a birth weight of ≤ 2000 
g,30 there were only 2 such cases in this study. Lampi 
Table 4. Comorbidities and related factors of ASD with intellectual disabilities
Comorbidities and related factors Number of patients Diagnosis (number of patients)
Perinatal abnormality 11
Low birth weight 5 Ultra-low-birth-weight infants (1), Low-birth-weight infants (4, cerebral palsy and epilepsy in 1)
Neonatal asphyxia 3
Meconium aspiration syndrome 3
Chromosomal abnormality/Congenital disorder 4 13q monosomy (2, epilepsy in 1), 46XXadd (1) (q42.1) (1), Angelman  syndrome (1, epilepsy)
Epilepsy 7 Severe myoclonic epilepsy in infancy (1), Infantile seizure (1), Secondary epilepsy (3)
Congenital anomaly of the brain 4 Macrocephaly (2), Callosal agenesis (1), Intracranial cyst (1)
Familial developmental disorder 1
Postnatal disorder 1 Sequela after acute encephalopathy
Total number 28 (real number 25)
ASD, autism spectrum disorders.
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et al.31 reported that low birth weight was a factor 
related to ASD, even controlling for birth order and 
gestational age. They did not bundle symptoms together 
and analyzed childhood autism (ASD with intellectual 
disabilities), Asperger’s syndrome (ASD without intel-
lectual disabilities), and PDD not otherwise specified 
(PDD-NOS) separately; the authors found that low birth 
weight was linked to childhood autism and PDD-NOS. 
Matsumoto32 hypothesized that genetic factors help 
determine the onset of autistic disorders in children with 
ASDs, whereas other conditions such as PDD-NOS are 
determined by genetic factors, coupled with external 
factors such as low birth weight. There were 3 cases of 
neonatal asphyxia and 3 cases of meconium aspiration 
syndrome in our study, implying that low oxygen during 
the neonatal period may correlate with ASD with intel-
lectual disabilities.
 According to a summary published by the Ministry 
of Health, Labour and Welfare of Japan,33 the average 
age of mothers giving birth in 1995 was 27.5 years for 
their first child and 29.3 years for their second child. In 
the present study, the average maternal age at birth was 
higher than previously-reported values. Regarding the 
father’s age at the time of birth, Tsuchiya et al.34 reported 
that fathers of children with ASD without intellectual 
disabilities were older than fathers of neurotypical 
children. They found that when the father was aged ≥ 
33 years at the time of birth, the ASD risk was approx-
imately three-fold greater than that when the father was 
aged ≤ 29 years. Although the present study focused on 
children with ASD and IQ scores < 70, the average age 
of the fathers was comparable at 34.1 years.
 In general, severe intellectual disabilities are rarer 
than mild or moderate intellectual disabilities. According 
to epidemiological research conducted by Bourke et al.35 
in western Australia, 15.0 out of 1000 births demonstrat-
ed mild to moderate intellectual disabilities, whereas 
severe intellectual disabilities were manifest in 1.2 out 
of every 1000 births. In addition, ASD occurred at a rate 
of 4.1, whereas ASD with intellectual disabilities oc-
curred at a rate of 2.6, more than twice the rate of ASD 
without intellectual disabilities (1.2). In this study, cases 
of children with ASD and severe intellectual disabilities 
comprised 32.1% of the total cases, implying that severe 
forms of intellectual disabilities were closely correlated 
to ASD.
 Epilepsy is a common comorbidity in children with 
ASD, especially those with lower IQ scores.36 According 
to a review by Woolfenden et al.37 1.8% of children aged 
< 12 years with ASD have epileptic seizures, whereas 
23.7% of children aged ≥ 12 years with ASD and intel-
lectual disabilities have epileptic seizures. There were 
7 cases with epilepsy in this study. Although ASD was 
previously not thought to occur with cerebral palsy, 
studies are gradually reporting patients with ASD and 
cerebral palsy, such as Kilincaslan et al.38 These authors 
reported that 15% of 126 children with cerebral palsy 
also exhibited ASD symptoms and 31.7% of those with 
IQ scores of 70 or less had ASD. Our results include 
one case of cerebral palsy. There are many cases of 
ASD symptoms in children with chromosomal and 
congenital anomalies, with Down’s syndrome being the 
best known.39 We had 4 cases with chromosomal and 
congenital anomalies.
 One limitation of this study was that the intelligence 
and developmental tests used to determine intellectual 
disabilities were not consistently matched to age.
 Although the concept of ASD had expanded due to 
the introduction of the DSM-5, it is important to provide 
treatment and support for children with ASD, with and 
without intellectual disabilities. Children with ASD and 
intellectual disabilities, and other forms of ASD, must 
be distinguished to allow more thorough consideration 
going forward.
The authors declare no conflicts of interest.
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